Citations

Clear

4 citation(s) found for "Singh, Vivek".

Precision or Pitfall? Evaluating the Accuracy of ICD-10 Coding for Cemented Total Hip Arthroplasty
Singh, Vivek , Jolissaint, Josef , Kohler, James , Goh, Megan H. , Chen, Antonia F. , Bedard, Nicholas A. , Springer, Bryan D. , Schwarzkopf, Ran , Jolissaint, Josef E , Kohler, James G , Bedard, Nicholas A , Chen, Antonia F

Mayo Clinic

Journal of Bone and Joint Surgery | November 16, 2023 | Volume: 106 | Issue: 1 | Pages: 56-61

10.2106/jbjs.23.00325 | PMID 37973050 Get It

Background: The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Procedure Coding System (ICD-10-PCS) was adopted in the U.S. in 2015. Proponents of the ICD-10-PCS have stated that its granularity allows for a more accurate representation of the types of procedures performed by including laterality, joint designation, and more detailed procedural data. However, other researchers have expressed concern that the increased number of codes adds further complexity that leads to inaccurate and inconsistent coding, rendering registry and research data based on ICD-10-PCS codes invalid and inaccurate. We aimed to determine the accuracy of the ICD-10-PCS for identifying cemented fixation in primary total hip arthroplasty (THA). Methods: We retrospectively reviewed all cemented primary THAs performed at 4 geographically diverse, academic medical centers between October 2015 and October 2020. Cemented fixation was identified from the ICD-10-PCS coding for each procedure. The accuracy of an ICD-10-PCS code relative to the surgical record was determined by postoperative radiograph and chart review, and cross-referencing with institution-level coding published by the American Joint Replacement Registry (AJRR) was also performed. Results: A total of 552 cemented THA cases were identified within the study period, of which 452 (81.9%) were correctly coded as cemented with the ICD-10-PCS. The proportion of cases that were correctly coded was 187 of 260 (72%) at Institution A, 158 of 185 (85%) at Institution B, 35 of 35 (100%) at Institution C, and 72 of 72 (100%) at Institution D. Of the 480 identified cemented THA cases at 3 of the 4 institutions, 403 (84%) were correctly reported as cemented to the AJRR (Institution A, 185 of 260 cases [71%]; Institution B, 185 of 185 [100%]; and Institution C, 33 of 35 [94%]). Lastly, of these 480 identified cemented THA cases, 317 (66%) were both correctly coded with the ICD-10-PCS and correctly reported as cemented to the AJRR. Conclusions: Our findings revealed existing discrepancies within multiple institutional data sets, which may lead to inaccurate reporting by the AJRR and other registries that rely on ICD-10-PCS coding. Caution should be exercised when utilizing ICD-10 procedural data to evaluate specific details from administrative claims databases as these inaccuracies present inherent challenges to data validity and interpretation.
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder
Kemp, David E. , Friedman, Edward S., Reilly-Harrington, Noreen A. , Sylvia, Louisa G. , Calabrese, Joseph R. , Rabideau, Dustin J. , Ketter, Terence A. , Thase, Michael E., Tohen, Mauricio , Bowden, Charles L., Brody, Benjamin D. , Deckersbach, Thilo , Kocsis, James H., Kinrys, Gustavo , Kamali, Masoud , McInnis, Melvin G. , Leon, Andrew C. , Faraone, Stephen V. , Nierenberg, Andrew A. , Shelton, Richard C. , McElroy, Susan L. , Singh, Vivek Kumar , Bernstein, Emily E. , Bobo, William V. , Kamali, Masoud , McInnis, Melvin G

Mayo Clinic

Acta Psychiatrica Scandinavica | June 26, 2015 | Volume: 133 | Issue: 2 | Pages: 144-153

10.1111/acps.12460 | PMID 26114830 Get It

ObjectiveExamine the effects of obesity and metabolic syndrome on outcome in bipolar disorder.MethodThe Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder (Bipolar CHOICE) study randomized 482 participants with bipolar disorder in a 6‐month trial comparing lithium‐ and quetiapine‐based treatment. Baseline variables were compared between groups with and without obesity, with and without abdominal obesity, and with and without metabolic syndrome respectively. The effects of baseline obesity, abdominal obesity, and metabolic syndrome on outcomes were examined using mixed effects linear regression models.ResultsAt baseline, 44.4% of participants had obesity, 48.0% had abdominal obesity, and 27.3% had metabolic syndrome; neither obesity, nor abdominal obesity, nor metabolic syndrome were associated with increased global severity, mood symptoms, or suicidality, or with poorer functioning or life satisfaction. Treatment groups did not differ on prevalence of obesity, abdominal obesity, or metabolic syndrome. By contrast, among the entire cohort, obesity was associated with less global improvement and less improvement in total mood and depressive symptoms, suicidality, functioning, and life satisfaction after 6 months of treatment. Abdominal obesity was associated with similar findings. Metabolic syndrome had no effect on outcome.ConclusionObesity and abdominal obesity, but not metabolic syndrome, were associated with less improvement after 6 months of lithium‐ or quetiapine‐based treatment.
Psychotherapy use in bipolar disorder: Association with functioning and illness severity
Sylvia, Louisa G. , Thase, Michael E., Reilly-Harrington, Noreen A. , Salcedo, Stephanie , Brody, Benjamin D. , Kinrys, Gustavo , Kemp, David E. , Shelton, Richard C. , Kocsis, James H., Kamali, Masoud , McInnis, Melvin G. , Friedman, Edward S., Tohen, Mauricio , Bowden, Charles L., Ketter, Terence A. , Calabrese, Joseph R. , Nierenberg, Andrew A. , Rabideau, Dustin J. , Elson, Constance M., Deckersbach, Thilo , Bobo, William V. , McElroy, Susan L. , Singh, Vivek Kumar , Kamali, Masoud , McInnis, Melvin G

Mayo Clinic

Australian & New Zealand Journal of Psychiatry | February 13, 2015 | Volume: 49 | Issue: 5 | Pages: 453-461

10.1177/0004867415569803 | PMID 25680360 Get It

Objective: This study examines characteristics of individuals with bipolar disorder who sought psychotherapy versus those who did not. Methods: Bipolar CHOICE was an 11-site comparative effectiveness study of lithium versus quetiapine in symptomatic outpatients ( N = 482) with bipolar disorder. At baseline, participants’ psychotherapy use within the past 3 months, mood, functioning, and overall health were assessed. Logistic regressions were used to test whether psychotherapy users and non-users differed on various demographic and clinical variables at baseline. Mixed-effects regression was used to determine whether psychotherapy groups differed on response to treatment over the 6-month study. Kaplan-Meier plots and log-rank tests were employed to test whether there were any differences in time to recovery (CGI-BP ≤ 2 for at least 8 weeks) between the groups. Results: Thirty one percent of participants reported using psychotherapy services. Psychotherapy users reported greater medication side effect burden than non-users and were more likely to have moderate to high suicide risk and at least one anxiety disorder. Participants not utilizing medications or psychotherapy had greater mania symptom severity, were younger, and less educated than medication only users. Medication only users were more likely to be married than the other participants. Conclusions: These data suggest that a minority of individuals with bipolar disorder attend psychotherapy services, and those that do have greater illness burden.
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)
Sylvia, Louisa G. , Shelton, Richard C. , Kemp, David E. , Bernstein, Emily E. , Friedman, Edward S., Brody, Benjamin D. , Tohen, Mauricio , Bowden, Charles L., Ketter, Terence A. , Deckersbach, Thilo , Thase, Michael E., Reilly-Harrington, Noreen A. , Nierenberg, Andrew A. , Rabideau, Dustin J. , Kinrys, Gustavo , Kocsis, James H., Kamali, Masoud , McInnis, Melvin G. , Calabrese, Joseph R. , McElroy, Susan L. , Singh, Vivek Kumar , Bobo, William V. , Kamali, Masoud , McInnis, Melvin G

Mayo Clinic

Bipolar Disorders | August 16, 2014 | Volume: 17 | Issue: 2 | Pages: 212-223

10.1111/bdi.12243 | PMID 25130321 Get It

ObjectivesIndividuals with bipolar disorder have high rates of other medical comorbidity, which is associated with higher mortality rates and worse course of illness. The present study examined common predictors of medical comorbidity.MethodsThe Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE) enrolled 482 participants with bipolar I or bipolar II disorder in a six‐month, randomized comparative effectiveness trial. Baseline assessments included current and lifetime DSM‐IV‐TR diagnoses, demographic information, psychiatric and medical history, severity of psychiatric symptoms, level of functioning, and a fasting blood draw. Medical comorbidities were categorized into two groups: cardiometabolic (e.g., diabetes, hyperlipidemia, and metabolic syndrome) and non‐cardiovascular (e.g., seizures, asthma, and cancer). Additionally, we looked at comorbid substance use (e.g., smoking and drug dependence).ResultsWe found that 96.3% of participants had at least one other medical comorbidity. Older age predicted a greater likelihood of having a cardiometabolic condition. Early age of onset of bipolar symptoms was associated with a lower chance of having a cardiometabolic condition, but a greater chance of having other types of medical comorbidity. Additional predictors of other medical comorbidities in bipolar disorder included more time spent depressed, less time spent manic/hypomanic, and longer duration of illness. Medications associated with weight gain were associated with low high‐density lipoprotein and abnormal triglycerides.ConclusionsThere appears to be a substantial medical burden associated with bipolar disorder, highlighting the need for collaborative care among psychiatric and general medical providers to address both psychiatric and other medical needs concomitantly in this group of patients.